EUDA Health Holdings Limited (NASDAQ:EUDA) Sees Large Drop in Short Interest

EUDA Health Holdings Limited (NASDAQ:EUDA) saw a large decline in short interest in the month of June. As of June 15th, there was short interest totaling 5,223 shares, a decline of 37.3% from the May 31st total of 8,334 shares. Currently, 0.2% of the company’s shares are short sold. Based on an average daily volume of 4,093 shares, the days-to-cover ratio is presently 1.3 days.

Institutional Trading of EUDA Health

A hedge fund recently bought a new position in EUDA Health stock. Jane Street Group LLC bought a new position in EUDA Health Holdings Limited (NASDAQ:EUDA) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 25,675 shares of the company’s stock, valued at approximately $59,000. Jane Street Group LLC owned approximately 0.07% of EUDA Health as of its most recent filing with the Securities and Exchange Commission (SEC). 4.35% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on EUDA shares. Greenridge Global decreased their target price on EUDA Health from $120.00 to $55.00 and set a “buy” rating for the company in a research note on Monday, March 9th. Weiss Ratings lowered EUDA Health from a “sell (d)” rating to a “sell (e+)” rating in a research note on Friday, May 8th. Finally, Zacks Research upgraded EUDA Health from a “strong sell” rating to a “hold” rating in a report on Friday, May 8th. One equities research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $55.00.

EUDA Health Stock Performance

NASDAQ:EUDA remained flat at $13.88 during trading hours on Friday. 2,355 shares of the company’s stock were exchanged, compared to its average volume of 4,488. The stock has a fifty day moving average price of $15.13 and a 200-day moving average price of $20.73. EUDA Health has a 1-year low of $5.26 and a 1-year high of $86.00. The company has a market capitalization of $41.50 million, a price-to-earnings ratio of -5.78 and a beta of 0.68.

EUDA Health (NASDAQ:EUDA) last released its earnings results on Tuesday, May 5th. The company reported ($0.44) EPS for the quarter, topping analysts’ consensus estimates of ($1.20) by $0.76. The company had revenue of $1.92 million during the quarter, compared to analysts’ expectations of $3.90 million. As a group, equities analysts predict that EUDA Health will post 1.6 EPS for the current year.

About EUDA Health

EUDA Health, Inc (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health.

EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation.